• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部 Merkel 细胞癌:潜在的组织病理学预测指标。

Merkel cell carcinoma of the head and neck: potential histopathologic predictors.

机构信息

Department of Otolaryngology-Head and Neck Surgery, Princess Margaret Cancer Centre/University Health Network, Toronto, Ontario, Canada.

出版信息

Laryngoscope. 2013 Dec;123(12):3043-8. doi: 10.1002/lary.24233. Epub 2013 Oct 10.

DOI:10.1002/lary.24233
PMID:23754774
Abstract

OBJECTIVES/HYPOTHESIS: To identify or confirm any new or suggested independent histopathological predictors in Merkel cell carcinoma (MCC) of the head and neck (HN) correlated with outcome.

STUDY DESIGN

Retrospective chart and pathology review.

METHODS

Between 1990 and 2010, 58 patients with Merkel cell carcinoma of the head and neck HNMCC were identified for study. Pathologic specimens were reviewed and evaluated for independent prognostic factors and correlated with locoregional recurrence and disease-specific survival.

RESULTS

The 2- and 5-year disease-specific survival (DSS) rates were 72.7% and 63.6%, respectively. The local and regional recurrence rates were 12.0% and 24.1%, respectively. A total of 25.9% of the patients developed distant metastases during follow-up. Tumor size (< 1 cm vs. > 1 cm) and the presence of a positive deep resection margin were independently found to be significantly associated with regional recurrence (P = 0.01 and P = 0.04, respectively). No other prognostic factors could be identified.

CONCLUSION

Adjuvant radiotherapy cannot remediate a positive resection margin. Given these results, consideration for revision surgery should be considered for a positive deep margin. Frozen section analysis may help to define the margins in this invasive and aggressive disease.

摘要

目的/假设:确定或确认与头颈部(HN)Merkel 细胞癌(MCC)结果相关的任何新的或建议的独立组织病理学预测因子。

研究设计

回顾性图表和病理审查。

方法

在 1990 年至 2010 年期间,确定了 58 例头颈部 Merkel 细胞癌 HN MCC 患者进行研究。对病理标本进行了回顾和评估,以确定独立的预后因素,并与局部区域复发和疾病特异性生存率相关。

结果

2 年和 5 年疾病特异性生存率(DSS)分别为 72.7%和 63.6%。局部和区域复发率分别为 12.0%和 24.1%。在随访期间,共有 25.9%的患者发生远处转移。肿瘤大小(<1cm 与>1cm)和存在阳性深部切缘被独立发现与区域复发显著相关(P=0.01 和 P=0.04)。没有发现其他预后因素。

结论

辅助放疗不能纠正阳性切缘。鉴于这些结果,对于阳性深部切缘应考虑进行修正手术。冰冻切片分析可能有助于在这种侵袭性和侵袭性疾病中确定边缘。

相似文献

1
Merkel cell carcinoma of the head and neck: potential histopathologic predictors.头颈部 Merkel 细胞癌:潜在的组织病理学预测指标。
Laryngoscope. 2013 Dec;123(12):3043-8. doi: 10.1002/lary.24233. Epub 2013 Oct 10.
2
Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data. Merkel 细胞癌:基于 SEER 数据分析,鉴定头颈部肿瘤特有的预后因素。
Laryngoscope. 2012 Jun;122(6):1283-90. doi: 10.1002/lary.23222. Epub 2012 Apr 20.
3
Tumor location is an independent prognostic factor in head and neck Merkel cell carcinoma.肿瘤位置是头颈部 Merkel 细胞癌的一个独立预后因素。
Otolaryngol Head Neck Surg. 2012 Mar;146(3):403-8. doi: 10.1177/0194599811431789. Epub 2011 Dec 13.
4
Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.基于36例病例及文献综述的头颈部默克尔细胞癌放射治疗控制分析
Ear Nose Throat J. 2008 Nov;87(11):634-43.
5
Merkel cell carcinoma of the head and neck: is adjuvant radiotherapy necessary?头颈部默克尔细胞癌:辅助放疗是否必要?
Head Neck. 2007 Mar;29(3):249-57. doi: 10.1002/hed.20510.
6
Merkel cell carcinoma: does tumor size or depth of invasion correlate with recurrence, metastasis, or patient survival?默克尔细胞癌:肿瘤大小或浸润深度与复发、转移或患者生存率相关吗?
Laryngoscope. 2006 May;116(5):791-5. doi: 10.1097/01.mlg.0000208615.93883.b2.
7
Benefits of combined modality treatment of Merkel cell carcinoma of the head and neck: single institution experience.头颈部默克尔细胞癌联合治疗模式的益处:单机构经验
J Laryngol Otol. 2013 Sep;127(9):908-16. doi: 10.1017/S0022215113001862. Epub 2013 Aug 19.
8
The role of adjuvant therapy in the management of head and neck merkel cell carcinoma: an analysis of 4815 patients.辅助治疗在头颈部默克尔细胞癌管理中的作用:对4815例患者的分析
JAMA Otolaryngol Head Neck Surg. 2015 Feb;141(2):137-41. doi: 10.1001/jamaoto.2014.3052.
9
Sentinel lymph node status in Merkel cell carcinoma of the head and neck: not a predictor of survival.头颈部默克尔细胞癌前哨淋巴结状态:并非生存的预测指标。
Head Neck. 2014 Apr;36(4):571-9. doi: 10.1002/hed.23334. Epub 2014 Jan 20.
10
Adjuvant local irradiation for Merkel cell carcinoma.默克尔细胞癌的辅助局部放疗。
Arch Dermatol. 2006 Jun;142(6):693-700. doi: 10.1001/archderm.142.6.693.

引用本文的文献

1
Survival of Patients With Head and Neck Merkel Cell Cancer: Findings From the Pan-Canadian Merkel Cell Cancer Collaborative.头颈部 Merkel 细胞癌患者的生存情况:来自加拿大 Merkel 细胞癌合作研究的结果。
JAMA Netw Open. 2023 Nov 1;6(11):e2344127. doi: 10.1001/jamanetworkopen.2023.44127.
2
The Evolving Treatment Landscape of Merkel Cell Carcinoma. Merkel 细胞癌治疗领域的不断发展。
Curr Treat Options Oncol. 2023 Sep;24(9):1231-1258. doi: 10.1007/s11864-023-01118-8. Epub 2023 Jul 5.
3
Best practices in surgical and nonsurgical management of head and neck Merkel cell carcinoma: An update.
头颈部 Merkel 细胞癌手术和非手术治疗的最佳实践:更新。
Mol Carcinog. 2023 Jan;62(1):101-112. doi: 10.1002/mc.23483. Epub 2022 Nov 11.